Brief: Salarius Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

Decoy Therapeutics

09/09/2025 13:10

Sept 9 (Reuters) - Salarius Pharmaceuticals Inc SLRX.O:

SALARIUS PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Source text: ID:nGNX8k7dzH

Further company coverage: SLRX.O

 ((Reuters.Briefs@thomsonreuters.com;))